SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-006991
Filing Date
2024-11-08
Accepted
2024-11-08 16:45:23
Documents
46
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q celz_10q.htm   iXBRL 10-Q 648297
2 CERTIFICATION celz_ex311.htm EX-31.1 12672
3 CERTIFICATION celz_ex312.htm EX-31.2 12525
4 CERTIFICATION celz_ex321.htm EX-32.1 5205
5 CERTIFICATION celz_ex322.htm EX-32.2 5266
11 celz_10qimg2.jpg GRAPHIC 44275
  Complete submission text file 0001477932-24-006991.txt   3182816

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA celz-20240930.xsd EX-101.SCH 32059
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE celz-20240930_lab.xml EX-101.LAB 208415
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celz-20240930_cal.xml EX-101.CAL 31038
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celz-20240930_pre.xml EX-101.PRE 174134
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celz-20240930_def.xml EX-101.DEF 112768
49 EXTRACTED XBRL INSTANCE DOCUMENT celz_10q_htm.xml XML 323025
Mailing Address 211 E. OSBORN RD. PHOENIX AZ 85012
Business Address 211 E. OSBORN RD. PHOENIX AZ 85012 480-399-2822
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001187953 (see all company filings)

IRS No.: 870622284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41120 | Film No.: 241441394
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)